Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
950.5 USD | +0.24% |
|
+3.54% | +63.05% |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
07-12 | Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.05% | 856B | |
+38.86% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.72% | 244B | |
+5.03% | 234B | |
+16.33% | 226B | |
+14.63% | 177B | |
+1.08% | 165B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company, Q4 2016 Earnings Call, Jan 31, 2017